The sodium channel auxiliary subunit beta4 (SCN4B) may act as a genetic modifier of conduction disease severity in cardiac sodium channelopathies.
No takes yet. Share an insight, caveat, or question.
SCN4B may modify conduction disease severity; animal data leave open human relevance and therapeutic targeting.
Remme et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: